Celecoxib - Druggability Technologies

Drug Profile

Celecoxib - Druggability Technologies

Alternative Names: DRGT 46; DRGT 47; DRGT 48

Latest Information Update: 22 Dec 2016

Price : $50

At a glance

  • Originator Druggability Technologies
  • Class Analgesics; Antirheumatics; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Pyrazoles; Small molecules; Sulfonamides
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Pain

Highest Development Phases

  • Phase I Pain

Most Recent Events

  • 19 Dec 2016 Pharmacokinetics data from a phase I trial in Pain released by Druggability Technologies
  • 12 Dec 2016 Chemical structure information added
  • 09 Dec 2016 Phase-I clinical trials in Pain (100mg) (Druggability pipeline, December 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top